A research team from the LKS Faculty of Medicine, the University of Hong Kong (HKUMed) has developed a new way to break through the current limited throughput in optimizing precise genome editors at scale, and engineer hundreds (or more) of base editor variants in parallel instead of via current laborious one-at-a-time testing, and inform users of the most suitable ones for therapeutic genome editing. The finding has been published in Cell Systems and a patent application has been filed based on this work.
Click here for original story, New platform slashes time to engineer and select the best genome editors for specific applications
Source: Phys.org